Your session is about to expire
← Back to Search
Procedure
1 for Interleukins
Phase 3
Waitlist Available
Led By Dennis Hong, MD., MS.c, FRCSC
Research Sponsored by Legacy Health System
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
undergoing laparoscopic gastric bypass, >18 yo, understands english
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
Study Summary
To see if removing the omentum in addition to a gastric bypass improves diabetes is better than just a gastric bypass.
Eligible Conditions
- Diabetes
- Interleukins
- Cytokines
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
diabetic indices
Secondary outcome measures
interleukin and cytokine levels, weight loss
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: 1Experimental Treatment1 Intervention
surgery plus omentectomy
Group II: 2Active Control1 Intervention
standard gastric bypass
Find a Location
Who is running the clinical trial?
Legacy Health SystemLead Sponsor
35 Previous Clinical Trials
3,641 Total Patients Enrolled
Dennis Hong, MD., MS.c, FRCSCPrincipal InvestigatorOregon Weight Loss Surgery, LLC
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger